On Tuesday, the FDA approved Eli Lilly and Co’s (NYSE:LLY) Kisunla (donanemab) once-monthly injection for IV infusion) for adults with early symptomatic Alzheimer’s disease. Once-monthly, Kisunla is ...
(Medical Xpress)—Researchers are close to commercializing a new type of medical imaging technology that could diagnose cardiovascular disease by measuring ultrasound signals from molecules exposed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results